Michel Dahan's Insider Trades & SAST Disclosures

Michel Dahan's most recent trade in Akebia Therapeutics Inc. was a trade of 34,840 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on May 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 May 2024 34,840 672,092 (0%) 0% 1.3 43,898 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.58 per share. 29 Feb 2024 8,661 706,932 (0%) 0% 1.6 13,684 Common Stock
Akebia Therapeutics Inc.
Dahan Michel SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.52 per share. 27 Feb 2024 10,744 715,593 (0%) 0% 1.5 16,331 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 224,000 224,000 - - Stock Option (Right to buy)
Akebia Therapeutics Inc.
Dahan Michel SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 149,300 726,337 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 200,000 669,515 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 200,000 200,000 - - Employee Stock Option (Right to buy)
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.22 per share. 24 May 2023 95,478 574,037 (0%) 0% 1.2 116,760 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 200,000 469,515 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.88 per share. 01 Mar 2023 10,476 271,393 (0%) 0% 0.9 9,193 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.88 per share. 01 Mar 2023 8,058 281,869 (0%) 0% 0.9 7,071 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.88 per share. 01 Mar 2023 1,878 269,515 (0%) 0% 0.9 1,648 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.81 per share. 27 Feb 2023 10,090 289,927 (0%) 0% 0.8 8,205 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2022 200,000 200,000 - - Employee Stock Option (Right to buy)
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2022 50,000 308,995 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.17 per share. 28 Feb 2022 6,873 295,249 (0%) 0% 2.2 14,919 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.17 per share. 28 Feb 2022 6,873 302,122 (0%) 0% 2.2 14,919 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.15 per share. 28 Feb 2022 6,555 258,995 (0%) 0% 2.2 14,125 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 2.17 per share. 28 Feb 2022 1,232 297,017 (0%) 0% 2.2 2,674 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 3.40 per share. 01 Apr 2021 1,211 265,550 (0%) 0% 3.4 4,117 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 11,648 266,761 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 110,000 110,000 - - Employee Stock Option (Right to buy)
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2021 62,000 269,660 (0%) 0% 0 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 3.40 per share. 26 Feb 2021 7,945 255,113 (0%) 0% 3.4 26,982 Common Stock
Akebia Therapeutics Inc.
Michel Dahan SVP, Chief Operating Officer Sale of securities on an exchange or to another person at price $ 3.40 per share. 26 Feb 2021 6,602 263,058 (0%) 0% 3.4 22,421 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades